Back to Search Start Over

Assessing immunogenicity barriers of the HIV-1 envelope trimer.

Authors :
Maliqi, Liridona
Friedrich, Nikolas
Glögl, Matthias
Schmutz, Stefan
Schmidt, Daniel
Rusert, Peter
Schanz, Merle
Zaheri, Maryam
Pasin, Chloé
Niklaus, Cyrille
Foulkes, Caio
Reinberg, Thomas
Dreier, Birgit
Abela, Irene
Peterhoff, David
Hauser, Alexandra
Kouyos, Roger D.
Günthard, Huldrych F.
van Gils, Marit J.
Sanders, Rogier W.
Source :
NPJ Vaccines; 9/30/2023, Vol. 8 Issue 1, p1-14, 14p
Publication Year :
2023

Abstract

Understanding the balance between epitope shielding and accessibility on HIV-1 envelope (Env) trimers is essential to guide immunogen selection for broadly neutralizing antibody (bnAb) based vaccines. To investigate the antigenic space of Env immunogens, we created a strategy based on synthetic, high diversity, Designed Ankyrin Repeat Protein (DARPin) libraries. We show that DARPin Antigenicity Analysis (DANA), a purely in vitro screening tool, has the capability to extrapolate relevant information of antigenic properties of Env immunogens. DANA screens of stabilized, soluble Env trimers revealed that stronger trimer stabilization led to the selection of highly mutated DARPins with length variations and framework mutations mirroring observations made for bnAbs. By mimicking heterotypic prime-boost immunization regimens, DANA may be used to select immunogen combinations that favor the selection of trimer-reactive binders. This positions DANA as a versatile strategy for distilling fundamental antigenic features of immunogens, complementary to preclinical immunogenicity testing. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20590105
Volume :
8
Issue :
1
Database :
Complementary Index
Journal :
NPJ Vaccines
Publication Type :
Academic Journal
Accession number :
172439391
Full Text :
https://doi.org/10.1038/s41541-023-00746-3